Published in Scand J Gastroenterol on August 19, 2013
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? J Neurogastroenterol Motil (2015) 1.23
Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol (2014) 0.97
Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2014) 0.85
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol (2014) 0.82
Immunomodulation of enteric neural function in irritable bowel syndrome. World J Gastroenterol (2015) 0.78
Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol (2016) 0.76
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview. Pharmacology (2015) 0.75
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome. BMC Gastroenterol (2017) 0.75
Reasons for diagnostic delay in gynecological malignancies. Int J Gynecol Cancer (2011) 2.11
A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2013) 1.51
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab. Dig Dis Sci (2015) 1.51
Prevalence of chronic rhinosinusitis in a population of patients with gastroesophageal reflux disease. Am J Rhinol Allergy (2015) 1.49
Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol (2010) 1.47
[Selective COX-2 inhibitors--side effects in relation to non-specific non-steroidal anti-inflammatory drugs]. Ugeskr Laeger (2004) 1.37
Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease. Gut (2008) 1.28
Prevalence of cancer alarm symptoms: a population-based cross-sectional study. Scand J Prim Health Care (2010) 1.17
Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice. Br J Gen Pract (2014) 1.05
Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study. Am J Gastroenterol (2006) 1.03
Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Scand J Gastroenterol (2014) 1.00
Unmet needs in cancer rehabilitation during the early cancer trajectory--a nationwide patient survey. Acta Oncol (2013) 0.97
Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care. Am J Gastroenterol (2013) 0.95
Incidental findings at MRI-enterography in patients with suspected or known Crohn's disease. World J Gastroenterol (2010) 0.95
Diagnostic accuracies of MR enterography and CT enterography in symptomatic Crohn's disease. Scand J Gastroenterol (2011) 0.95
Diagnosis and treatment of Helicobacter pylori infection. Dan Med Bull (2011) 0.94
The risk of missed gastroesophageal cancer diagnoses in users and nonusers of antisecretory medication. Gastroenterology (2005) 0.94
Lack of spirometry use in Danish patients initiating medication targeting obstructive lung disease. Respir Med (2012) 0.92
Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon. Scand J Gastroenterol (2011) 0.92
Comparison of the medical students' perceived self-efficacy and the evaluation of the observers and patients. BMC Med Educ (2013) 0.90
Incidence, prevalence, etiology, and prognosis of first-time chronic pancreatitis in young patients: a nationwide cohort study. Dig Dis Sci (2010) 0.88
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis (2014) 0.87
Prevalence of overweight and obesity in Danish preschool children over a 10-year period: a study of two birth cohorts in general practice. Acta Paediatr (2012) 0.86
Laparoscopic and Percutaneous Core Needle Biopsy Plays a Central Role for the Diagnosis of Autoimmune Pancreatitis in a Single-Center Study From Denmark. Pancreas (2015) 0.85
Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey. BMC Med Inform Decis Mak (2012) 0.84
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study. Inflamm Bowel Dis (2015) 0.84
The danish model for improvement of diabetes care in general practice: impact of automated collection and feedback of patient data. Int J Family Med (2012) 0.83
Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. Pancreas (2013) 0.83
Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: a nationwide observational study. Eur J Gen Pract (2014) 0.82
Prevalence and management of patients using medication targeting obstructive lung disease: a cross-sectional study in primary healthcare in Greenland. Int J Circumpolar Health (2013) 0.82
Postpartum infections: occurrence, healthcare contacts and association with breastfeeding. Acta Obstet Gynecol Scand (2012) 0.82
Inter-observer agreement for detection of small bowel Crohn's disease with capsule endoscopy. Scand J Gastroenterol (2010) 0.81
Associations between reporting of cancer alarm symptoms and socioeconomic and demographic determinants: a population-based, cross-sectional study. BMC Public Health (2012) 0.80
Ileoscopy reduces the need for small bowel imaging in suspected Crohn's disease. Dan Med J (2012) 0.80
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment. Dan Med J (2012) 0.80
A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol (2010) 0.80
Prevalence of the use of antihypertensive medications in Greenland: a study of quality of care amongst patients treated with antihypertensive drugs. Int J Circumpolar Health (2012) 0.79
Circulating microRNAs as biomarkers of adult Crohn's disease. Eur J Gastroenterol Hepatol (2015) 0.79
Association between prescribing patterns of anti-asthmatic drugs and clinically uncontrolled asthma: a cross-sectional study. Pulm Pharmacol Ther (2011) 0.79
Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study. BMJ (2003) 0.78
Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice. BMC Health Serv Res (2013) 0.78
Sexual function and body image are similar after laparoscopy-assisted and open ileal pouch-anal anastomosis. World J Surg (2014) 0.78
[Treatment of bleeding gastroduodenal ulcer]. Ugeskr Laeger (2007) 0.78
Multiple perspectives on symptom interpretation in primary care research. BMC Fam Pract (2013) 0.77
[Probiotics--should we change the treatment strategy for pouchitis?]. Ugeskr Laeger (2006) 0.77
High sensitivity of quick view capsule endoscopy for detection of small bowel Crohn's disease. J Gastroenterol Hepatol (2014) 0.77
[Hepatocellular carcinoma and other liver tumors]. Ugeskr Laeger (2006) 0.75
A rare cause of severe hepatomegaly with an improving outcome. BMJ Case Rep (2014) 0.75
Prophylactic arterial embolization in high-risk peptic ulcer bleeding after endoscopic hemostasis is achieved: a new step - authors' reply. Scand J Gastroenterol (2014) 0.75
Biologic therapy in inflammatory bowel disease. Dan Med J (2013) 0.75
[Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid]. Ugeskr Laeger (2009) 0.75
[Picture of the month: buried bumper syndrome]. Ugeskr Laeger (2006) 0.75
[Enteric-coated aspirin does not reduce the risk of gastrointestinal side effects]. Ugeskr Laeger (2014) 0.75
Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight. Inflamm Bowel Dis (2017) 0.75
Alarm symptoms of upper gastrointestinal cancer and contact to general practice--A population-based study. Scand J Gastroenterol (2015) 0.75
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75
Variation in examination and treatment offers to patients with allergic diseases in general practice. Qual Prim Care (2010) 0.75
[Diagnostic imaging and endoscopic methods in Crohn's disease of the small intestine]. Ugeskr Laeger (2009) 0.75
Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons. Metab Brain Dis (2014) 0.75
Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid. Basic Clin Pharmacol Toxicol (2014) 0.75
Consultation expectations among patients with respiratory tract infection symptoms. Dan Med J (2017) 0.75
The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75
[Two cases of the rare Cronkhite-Canada syndrome]. Ugeskr Laeger (2017) 0.75